Skip to content
The Weight Clinic
← Blog Weight & related conditions

Weight loss injections with type 2 diabetes UK

A person with type 2 diabetes preparing a weekly weight-loss injection pen at a kitchen table
Medically reviewed by Ali Al Sibahi, Pharmacist Independent Prescriber (GPhC 2225108) · 21 November 2026

Yes — adults in the UK who have type 2 diabetes can often be prescribed a weight-loss injection such as Mounjaro (tirzepatide) or Wegovy (semaglutide), provided they meet the eligibility criteria and a GPhC-registered prescriber judges it clinically appropriate. In fact, type 2 diabetes is one of the weight-related conditions that lowers the BMI threshold at which treatment can be considered.

Can you have weight loss injections if you have type 2 diabetes?

Adults with type 2 diabetes can usually be considered for a GLP-1 weight-loss injection in the UK, because type 2 diabetes is a recognised weight-related condition. That means treatment may be appropriate at a BMI of 27 or more (rather than the usual 30 or more), as long as a registered prescriber confirms it is safe and suitable for you after a consultation.

These medicines are Prescription-Only Medicines. They are supplied only after a free online consultation in which a GPhC-registered prescriber reviews your health, your diabetes control and your other medicines. You can begin with our free eligibility check.

Who is eligible if you live with type 2 diabetes?

Eligibility for weight-loss injections in the UK is the same framework for everyone, with type 2 diabetes acting as a qualifying weight-related condition. You may be considered if you meet all of the following:

  • Aged 18 or over.
  • A BMI of 30 or more, or a BMI of 27 or more alongside a weight-related condition such as type 2 diabetes, high blood pressure or sleep apnoea.
  • No medical reason that rules the medicine out (see the next section).

A treatment is prescribed only if it is clinically appropriate after your consultation — it is never guaranteed. You can read more about each option on our treatments overview.

Why do GLP-1 injections help with both weight and type 2 diabetes?

GLP-1 injections help with weight because they mimic a natural gut hormone that controls appetite — you feel fuller sooner and for longer, and the stomach empties more slowly, so you tend to eat less. The same hormone pathway also influences blood sugar, which is why this class of medicine is used in diabetes care.

Mounjaro (tirzepatide) works on two gut-hormone receptors at once — GLP-1 and GIP — while Wegovy (semaglutide) works on the GLP-1 receptor alone. On this service these medicines are prescribed for weight management; your diabetes team remains responsible for your overall diabetes care and may need to adjust your other glucose-lowering medicines.

Which weight-loss medicines are available in the UK?

Several MHRA-licensed options are available, as weekly injections, a daily tablet, or a small-molecule tablet. The table below summarises how each is taken and the single trial efficacy figure permitted for it. Individual results vary; not everyone reaches this.

Licensed weight-management medicines and how they are taken
MedicineHow it is takenTrial weight-loss figure
Mounjaro (tirzepatide)Weekly self-injection22.5% on the 15mg dose over 72 weeks (SURMOUNT-1)
Wegovy injection (semaglutide)Weekly self-injection20.7% on the 7.2mg dose over 72 weeks (STEP UP)
Wegovy Tablet (oral semaglutide)Once-daily tablet on an empty stomach16.6% on the 25mg dose over 64 weeks (OASIS 4)
Foundayo (orforglipron)Once-daily tablet, any time, with or without food12.4% on the 36mg trial dose over 72 weeks (ATTAIN-1)

Individual results vary; not everyone reaches this. The 36mg orforglipron figure is the trial capsule dose and is above our maximum 17.2mg tablet, so it is not tied to a strength we supply. See the full range on our weight-loss injections page.

What is the main safety point for people on diabetes medicines?

The most important safety point if you have type 2 diabetes is the risk of low blood sugar (hypoglycaemia). GLP-1 medicines rarely cause hypos on their own, but when combined with insulin or a sulfonylurea (such as gliclazide) the risk rises, so your prescriber and diabetes team may need to adjust those medicines and advise closer blood-sugar monitoring.

Severe hypoglycaemia is listed as a serious but rare reaction. Always tell your prescriber at consultation exactly which diabetes medicines you take — this directly affects whether, and how, a weight-loss injection is prescribed for you.

Who should not take these injections?

These medicines are not suitable for everyone, and some conditions rule them out entirely. A weight-loss injection is generally not prescribed if you have any of the following:

  • Pregnancy, planning pregnancy, or breastfeeding.
  • Type 1 diabetes (these medicines are for weight management, and in this context type 2 diabetes only).
  • A personal or family history of medullary thyroid carcinoma or MEN2.
  • A history of pancreatitis or severe gastrointestinal disease.
  • An active eating disorder.
  • Severe liver or kidney impairment, or a known allergy to the active ingredient.

What side effects should you watch for?

The most common side effects of GLP-1 weight-loss injections affect the gut and appetite, and usually ease as your body adjusts and the dose is increased slowly. More than 1 in 10 people experience nausea, diarrhoea, constipation, vomiting, decreased appetite or fatigue.

Serious but rare effects include severe allergic reaction, acute pancreatitis, severe hypoglycaemia, severe gastrointestinal disease and worsening diabetic retinopathy — the last being especially relevant if you have diabetes-related eye disease, so mention any eye problems at your consultation. You can report any suspected side effect through the MHRA Yellow Card scheme at https://yellowcard.mhra.gov.uk/.

How do you start treatment safely with type 2 diabetes?

You start by completing a free online consultation so a GPhC-registered independent prescriber can review your health, your BMI, your diabetes control and all your current medicines before deciding whether treatment is appropriate. If suitable, the medicine is dispensed by our own UK pharmacy and sent by tracked delivery, with ongoing prescriber support.

Every treatment starts at the lowest dose and is titrated upward gradually, which helps limit side effects and allows your diabetes medicines to be adjusted safely. Begin your free consultation, or read more about The Weight Clinic and how our regulated process works.

This article is for information only and is not a substitute for personalised medical advice. Weight-loss medicines are prescription-only, are not suitable for everyone, and are prescribed only after a clinical consultation with a GPhC-registered prescriber. Individual results vary. Always speak to a UK-registered pharmacist or doctor before starting or changing any prescription medication.

Related reading

Check eligibility →